The impact of changes in drug availability for hemodynamic management in pheochromocytoma: prêt-à-porter or tailor-made?
Author:
Open Access
- 11 September 2015
- journal article
- editorial
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 62 (12) , 1244-1247
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case reportCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2015
- Pheochromocytoma resection: Current concepts in anesthetic managementJournal of Anaesthesiology Clinical Pharmacology, 2015
- Recognition and management of phaeochromocytomaAnaesthesia & Intensive Care Medicine, 2014
- Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic featuresEndocrine, 2013
- Urapidil in the Preoperative Treatment of Pheochromocytomas: A Safe and Cost‐effective MethodWorld Journal of Surgery, 2013
- Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomasSurgery, 2012
- Point of controversy: perioperative care of patients undergoing pheochromocytoma removal–time for a reappraisal?European Journal of Endocrinology, 2011
- Catecholamine metabolomic and secretory phenotypes in phaeochromocytomaEndocrine-Related Cancer, 2010
- The Protean Manifestations of PheochromocytomaHormone and Metabolic Research, 2009
- The Use of Magnesium Sulfate in the Anesthetic Management of PheochromocytomaAnesthesiology, 1985